How Fair Is the Standard of Care? Feb 25, 2024 If every patient is unique, can an overarching metric really be pinned down enough to declare that a given doctor was negligent as a legal certainty? Read More
Valid Biomarker Predicts Local Regrowth and Distant Metastasis in Rectal Cancer Dec 5, 2023 For patients with rectal cancer, no biomarker capable of improving monitoring and selection exists for those managed with a watch-and-wait (W&W) strategy, notes Franck Pagès, MD, PhD. Following neoadjuvant chemoradiotherapy,... Read More
Prevalence of Hearing Loss Significantly Higher for Cancer Survivors Dec 4, 2023 Cancer survivors have a significantly higher prevalence of hearing loss (HL) than the general... Read More
NCCN: US Cancer Centers Still Experiencing Shortages of Chemo Drugs Dec 3, 2023 Many cancer centers are still experiencing a shortage of carboplatin, cisplatin, and other... Read More
Shorter Courses of Radiotherapy Increasingly Used for Prostate Cancer Dec 1, 2023 From 2004 to 2020, there was an increase in the use of shorter radiotherapy (RT) courses... Read More
Multicancer Early Detection Blood Tests Are Feasible Nov 30, 2023 Multicancer early detection (MCED) blood tests are feasible for detecting cancer, according to a... Read More